Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06542835 · ClinicalTrials.gov registry record · NA

Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity

A NA study of Colorectal Cancer, sponsored by University of Arizona.

Recruiting
Registry status
NA
Development phase
6,000
Enrollment target
1
Study location

NCT06542835 is a NA study of Colorectal Cancer that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 6,000 participants, above the 1,495-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (301% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06542835, a NA study of Colorectal Cancer, is actively recruiting participants, sponsored by University of Arizona.

RECRUITING
Registry status
NA
Development phase
6,000 participants
Enrollment target
1
Study location

Study Summary

Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Video text message
  • BEHAVIORAL In-clinic CRC screening promotion
  • BEHAVIORAL Mailed FIT
  • BEHAVIORAL Social needs navigation
  • BEHAVIORAL Reminders

Study Locations (1)

California

  • AltaMed Health Services Corporation - Los Angeles

Trial Details

FieldValue
Enrollment Target 6,000 participants
Start Date 2024-07-31
Est. Completion 2027-01
Phase NA

Sponsor

University of Arizona

349 total trials

What the Registry Record Tells You About NCT06542835

The ClinicalTrials.gov registry entry for NCT06542835 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 6,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,495-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (301% higher). The listed sponsor is University of Arizona, which has 349 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 5 interventions - of which Video text message is the first listed.

NCT06542835 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06542835 about?

NCT06542835 is a clinical study titled "Community Partnership for Telehealth Solutions to Counter Misinformation and Achieve Equity". Non-randomized, two-arm stepped-wedge trial of a multi-level colorectal cancer screening intervention.

What is the current status of trial NCT06542835?

This trial is currently recruiting. It is a NA study. The enrollment target is 6,000 participants. The study started on 2024-07-31. Estimated completion is 2027-01.

What conditions does trial NCT06542835 study?

This clinical trial studies the following conditions: Colorectal Cancer.

What interventions are being tested in trial NCT06542835?

The interventions under investigation include: Video text message (BEHAVIORAL), In-clinic CRC screening promotion (BEHAVIORAL), Mailed FIT (BEHAVIORAL), Social needs navigation (BEHAVIORAL), Reminders (BEHAVIORAL).

Who is sponsoring clinical trial NCT06542835?

This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06542835 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.